ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Checkpoint Therapeutics, Inc. ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-55.65%
EBIT Growth (5y)
-188.17%
EBIT to Interest (avg)
-49.14
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.03
Sales to Capital Employed (avg)
-0.01
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
79.03%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
22.75
EV to EBIT
-5.99
EV to EBITDA
-5.99
EV to Capital Employed
-20.16
EV to Sales
337.66
PEG Ratio
NA
Dividend Yield
23.88%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-345.95%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -36.32 MM
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -202.77 %
-11What is not working for the Company
NET PROFIT(HY)
At USD -39.98 MM has Grown at -89.37%
ROCE(HY)
Lowest at -1,869.55%
DEBTORS TURNOVER RATIO(HY)
Lowest at 0%
Here's what is working for Checkpoint Therapeutics, Inc.
Operating Cash Flow
Highest at USD -36.32 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Lowest at -202.77 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Checkpoint Therapeutics, Inc.
Net Profit
At USD -39.98 MM has Grown at -89.37%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Debtors Turnover Ratio
Lowest at 0%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
